Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by shoosh22on Aug 20, 2020 11:40am
197 Views
Post# 31433856

RE:READ THE NR AGAIN

RE:READ THE NR AGAIN
whatdoiknow123 wrote: Absolute BS. If the results were good, it would be obvious and they would have been published today. The delay points to something very different indeed.

Wrote Mikey H, a genuinely helpful chap who appeared recently, along with some friends of his, to help us out and point out how corrupt Sona is. 

Read the NR.

1. It seems  obvious that they will already have some initial feedback on the results.
2. Before releasing the results they will need to digest them in their entirety and produce a report suitable to MRI,FDA,HC etc.
3. The new clinical trials are quite complex(just read the format in which the submission has to be made to the FDA) and will take time to formulate.
4. If they had been made aware of any significant problems with the results that would be MATERIAL NEWS  and they would need to release that as soon as they are aware of it.
5. Sona say in the NR that the data from the trials WILL be used in the submissions to HC  and FDA.  Not MIGHT or MAY  but WILL.
6. They could not say that if they were aware of any problems that would make a submission impossible which means, I believe, that they know they have achieved the minimum sensitivity necessary to allow a submission.

I am sure we will have good news soon ( although I honestly believe that the NR today is good news if you read it carefully and between the lines).


It's absolutely good news.  You are correct they used "will"   If results were not good they would not submit them.  

Plus we learned Sona is going after another FDA HC approval for their GNR's to be used INVIVO drug delivery... That is the secret sauce.. Their GNR's can be ingested.. All kinds of uses.. a Disruptive tech for the whole testing industry...  They are good.. we are good.. Share price is up already...  GLTA

<< Previous
Bullboard Posts
Next >>